High-dose MDMA does not result in long-term changes in impulsivity in the rat

Psychopharmacology

Volumn 188, Issue 1, 2006, Pages 75-83

  Saadat, Kathryn S ^a   Elliott, J Martin ^a   Green, A Richard ^b   Moran, Paula M ^b  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Dark Agouti; Impulsivity; MDMA ("ecstasy"); Serotonin; Vigilance

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMPULSIVENESS; INHIBITION (PSYCHOLOGY); INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; STIMULUS RESPONSE; TASK PERFORMANCE; TRANQUILIZING ACTIVITY; VISUAL DISCRIMINATION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; BIAS (EPIDEMIOLOGY); BRAIN; CONDITIONING, OPERANT; HALLUCINOGENS; HYDROXYINDOLEACETIC ACID; IMPULSIVE BEHAVIOR; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; REACTION TIME; SEROTONIN; TIME FACTORS;

EID: 33747619141     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0470-8     Document Type: Article

References (40)

1. Balogh B, Molnar E, Jakus R, Olverman HJ, Kelly PAT, Kantor S, Bagdy G (2004) Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology 173:296-309
2. Battaglia G, Brooks BP, Kulsakdinum C, Desouza EB (1988) Pharmacologic profile of MDMA (3,4-Methylenedioxymethamphetamine) at various brain recognition sites. Eur J Pharmacol 149(1-2):159-163
3. Bizot JC, Le Bihan C, Puech AJ, Hamon M, Thiebot MH (1999) Serotonin and tolerance to delay of reward in rats. Psychopharmacology 146:400-412
4. Butler GKL, Montgomery AMJ (2004) Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. Drug Alcohol Depend 76:55-62
5. Chudasama Y, Passetti F, Rhodes SEV, Lopian D, Desai A, Robbins TW (2003) Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146:105-119
6. Colado MI, O'Shea E, Green AR (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173:249-263
7. Denk F, Walton ME, Jennings KA, Sharp T, Rushworth MFS, Bannerman DM (2005) Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology 179:587-596
8. Gamma A, Brandeis D, Brandeis R, Vollenweider FX (2005) The P3 in 'ecstasy' polydrug users during response inhibition and execution. J Psychopharmacol 19:504-512
9. Gerbing DW, Ahadi SA, Patton JH (1987) Toward a conceptualization of impulsivity - components across the behavioral and self-report domains. Multivariate Behav Res 22:357-379
10. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719-725
11. Green AR, McGregor IS (2002) On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA. Psychopharmacology 164:448-450
12. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55: 463-508
13. Green AR, O'Shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures Br J Pharmacol 146:306-312
14. Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D (2004) Residual neuropsychological effects of illicit 3,4- methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75:135-147
15. Hanson KL, Luciana M (2004) Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychol Med 34:229-246
16. Malle BF, Neubauer AC (1991) Impulsivity, reflection, and questionnaire response latencies-no evidence for a broad impulsivity trait. Pers Individ Differ 12:865-871
17. McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (±) 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) - a controlled study in humans. Neuropsychopharmacology 10:129-138
18. McCann UD, Szabo A, Scheffel U, Dannals RF, Ricaurte GA (1998) Neurotoxic effects in human brains after use of 3,4-methylenedioxymethamphetamine ("ecstasy") viewed by positron emission tomography. Lancet 352:1433-1437
19. McGregor IS, Clemens KJ, Van der Plasse G, Li KM, Hunt GE, Chen F, Lawrence AJ (2003) Increased anxiety 3 months after brief exposure to MDMA ('ecstasy') in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology 28:1472-1484
20. Mechan AO, Moran PM, Elliott JM, Young AMJ, Joseph MH, Green AR (2002a) A study of the effect of a single neurotoxic dose of 3,4- methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field. Psychopharmacology 159:167-175
21. Mechan AO, Moran PM, Elliott JM, Young AMJ, Joseph MH, Green AR (2002b) A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus maze, open field apparatus and activity meters, and their response to diazepam. Psychopharmacology 159:188-195
22. Moeller FG, Dougherty DM, Barratt ES, Schmitz JM, Swann AC, Grabowski J (2001) The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 21:193-198
23. Morgan MJ (1998) Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252-264
24. O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998). The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37:919-926
25. O'Shea E, Orio L, Escobedo I, Sanchez V, Camarero J, Green AR, Colado MI (2006) MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature Br J Pharmacol DOI 10.1038/sj.bjp.0706783
26. Parrott AC (2002) Recreational ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 71:837-844
27. Parrott AC, Sisk E, Turner JJD (2000) Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug Alcohol Depend 60:105-110
28. Petry NM (2001) Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend 63:29-38
29. Piper BJ, Fraiman JB, Meyer JS (2005) Repeated MDMA ("ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention and serotonin transporter binding. Dev Psychobiol 47:145-157
30. Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott A (2001) Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study. Hum Psychopharmacol 16:619-625
31. Schifano F, Di Furia L, Forza C, Minicuci N, Bricolo R (1998) MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 52:85-90
32. Schmidt CJ, Taylor VL (1987) Depression of rat-brain tryptophanhydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol 36 (23):4095-4102
33. Sher KJ, Trull TJ (1994) Personality and disinhibitory psychopathology-alcoholism and antisocial personality disorder. J Abnorm Psychol 103:92-102
34. Sher KJ, Bartholow BD, Wood MD (2000) Personality and substance use disorders: a prospective study. J Consult Clin Psychol 68:818-829
35. Semple SJ, Zians J, Grant I, Patterson TL (2005) Impulsivity and methamphetamine use. J Subst Abuse Treat 29:85-93
36. Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt, A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167:85-96
37. Travers KR, Lyvers M (2005) Mood and impulsivity of recreational ecstasy users in the week following a "rave." Addiction Research and Theory 13:43-52
38. Verkes RJ, Gijsman HJ, Pieters MSM, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJM, de Bruin D, Van de Wijngaart G, Van Gerven JMA, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196-202
39. Weir E (2000) Raves: a review of the culture, the drugs and the prevention of harm. CMAJ 162:1843-1848
40. Yip JTH, Lee TMC (2005) Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology 179:620-628